InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by DAMELIO FRANK A, Director. Director active across 2 companies, notably Zoetis Inc.. In total, 4 disclosures have been recorded. Total volume traded: €856k. The latest transaction was disclosed on 13 May 2026 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
US$427,9126,650 shares@ US$64.34760.0014% mcap100.0% of flow
Common Stock
SEC:0001628280-26-034643·
Ideal exit: 7 Feb 2027 (T+270)
€427,9126,650 shares@ €64.34760.0014% mcap50.0% of flow
Common Stock
SEC:0001628280-26-034643:0·
Ideal exit: 7 Feb 2027 (T+270)
€3m127,160 shares@ €22.87620.0020% mcap43.9% of flow
Common Stock
SEC:0001225208-22-003723:0·
€4m153,789 shares@ €24.13250.0026% mcap56.1% of flow
Common Stock
SEC:0001225208-22-003466:0·
4 of 4 declarations
About DAMELIO FRANK A
Frank A. Damelio is a Director and Executive Vice President at Zoetis Inc. and Pfizer Inc. In these roles, he contributes to the strategic direction of the companies, which specialize in animal and pharmaceutical health. Mr. Damelio brings his expertise in governance and operations management to the board, actively participating in discussions on policies and company objectives.
